Distortion-corrected T2 weighted MRI: a novel approach to prostate radiotherapy planning.
Authors
Jackson, AndrewReinsberg, S A
Sohaib, S A
Charles-Edwards, E M
Mangar, Stephen A
South, C P
Leach, Martin O
Dearnaley, David P
Affiliation
Academic Department of Radiotherapy and Oncology, Royal Marsden Hospital and Institute of Cancer Research, Downs Rd, Sutton SM2 5PT, UK. Andrew.Jackson@manchester.ac.ukIssue Date
2007-11
Metadata
Show full item recordAbstract
The purpose of this study was to evaluate distortion-corrected MRI as a radiotherapy planning tool for prostate cancer and the resultant implications for dose sparing of organs at risk. 11 men who were to be treated with radical conformal radiotherapy for localized prostate cancer had an MRI scan under radiotherapy planning conditions, which was corrected for geometric distortion. Radiotherapy plans were created for planning target volumes derived from the MRI- and CT-defined prostate. Dose volume histograms were produced for the rectum, bladder and penile bulb. The mean volume of the prostate as defined on CT and MRI was 41 cm3 and 36 cm3, respectively (p = 0.009). The predicted percentage of the rectum treated to dose levels of 45-65 Gy was significantly lower for plans delineating the prostate with MRI than for those with CT. The rectal-sparing effect was confined to the lowermost 4 cm of the rectum (anal canal). There were no differences between the predicted doses to bladder or penile bulb (as defined using MRI) between plans. In conclusion, prostate radiotherapy planning based on distortion-corrected MRI is feasible and results in a smaller target volume than does CT. This leads to a lower predicted proportion of the rectum, in particular the lower rectum (anal canal), treated to a given dose than with CT.Citation
Distortion-corrected T2 weighted MRI: a novel approach to prostate radiotherapy planning. 2007, 80 (959):926-33 Br J RadiolJournal
The British Journal of RadiologyDOI
10.1259/bjr/51363812PubMed ID
17908816Type
ArticleLanguage
enISSN
1748-880Xae974a485f413a2113503eed53cd6c53
10.1259/bjr/51363812
Scopus Count
Collections
Related articles
- MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
- Authors: Chen L, Price RA Jr, Wang L, Li J, Qin L, McNeeley S, Ma CM, Freedman GM, Pollack A
- Issue date: 2004 Oct 1
- Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities.
- Authors: Seppälä T, Visapää H, Collan J, Kapanen M, Beule A, Kouri M, Tenhunen M, Saarilahti K
- Issue date: 2015 Nov
- Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
- Authors: Sanguineti G, Castellone P, Foppiano F, Franzone P, Marcenaro M, Tognoni P, Bolognesi A, Ceresoli GL, Fiorino C
- Issue date: 2004 Sep
- Dosimetric evaluation of MRI-based treatment planning for prostate cancer.
- Authors: Chen L, Price RA Jr, Nguyen TB, Wang L, Li JS, Qin L, Ding M, Palacio E, Ma CM, Pollack A
- Issue date: 2004 Nov 21
- Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study.
- Authors: Cassidy RJ, Yang X, Liu T, Thomas M, Nour SG, Jani AB
- Issue date: 2016 Winter